Competitive analysis in Peptide Drugs industry

Top companies filing patent oppositions

Total Oppositions
38
Total Oppositions
29
Total Oppositions
25
Total Oppositions
18
Company
Total Oppositions
17
Total Oppositions
16
Total Oppositions
16
Total Oppositions
15
Total Oppositions
14
Total Oppositions
13

Top companies facing patent oppositions

Total Oppositions
94
Total Oppositions
33
Total Oppositions
33
Company
Total Oppositions
25
Company
Total Oppositions
19
Company
Total Oppositions
18
Total Oppositions
16
Total Oppositions
16
Total Oppositions
15

Latest patents granted in the Peptide Drugs industry

Patent:
Grant Date:
Oct 16, 2024
Title:
Long - Acting Formulations Of Insulins
Applicant:
Patent:
Grant Date:
Sep 25, 2024
Title:
Formula Of Neuregulin Preparation
Patent:
Grant Date:
Sep 25, 2024
Title:
Drug Delivery Compositions And Uses Thereof
Patent:
Grant Date:
Sep 25, 2024
Title:
Central Memory T Cells For Adoptive T Cell Therapy
Applicant:
Patent:
Grant Date:
Sep 4, 2024
Title:
Beta-Casein A2 And Blood Glucose Levels
Patent:
Grant Date:
Aug 28, 2024
Title:
Botulinum Toxin Prefilled Container
Patent:
Grant Date:
Jun 12, 2024
Title:
Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof
Patent:
Grant Date:
May 1, 2024
Title:
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
Patent:
Grant Date:
Apr 3, 2024
Title:
Aav-Mediated Gene Therapy Restoring The Otoferlin Gene
Patent:
Grant Date:
Jan 10, 2024
Title:
Improved Protocol For Treatment Of Lupus Nephritis

Top patents facing oppositions in Peptide Drugs industry

Patent
Grant Date
Oct 12, 2022
Title
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
Oppositions
36
Patent
Grant Date
Jun 28, 2017
Title
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency
Oppositions
30
Patent
Grant Date
Aug 2, 2023
Title
Gip/Glp1 Agonist Compositions
Oppositions
21
Patent
Grant Date
Jun 26, 2019
Title
Rna Containing Composition For Treatment Of Tumor Diseases
Applicant
Oppositions
20
Patent
Grant Date
Nov 22, 2017
Title
Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices
Oppositions
18
Patent
Grant Date
May 4, 2022
Title
Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof
Oppositions
18
Patent
Grant Date
Jan 4, 2017
Title
Low Frequency Glatiramer Acetate Therapy
Oppositions
18
Patent
Grant Date
Dec 11, 2019
Title
Methods Of Treating Hepatic Encephalopathy
Oppositions
16
Patent
Grant Date
Jun 26, 2019
Title
Rna Containing Composition For Treatment Of Tumor Diseases
Applicant
Oppositions
16
Patent
Grant Date
Oct 26, 2022
Title
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist
Applicant
Oppositions
16

Need more information?

Feel free to send us a message here and we will get back to you